The Abbott RealTime HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of hepatitis C viral ribonucleic acid (HCV RNA) in human serum and plasma from HCV-infected individuals. The Abbott RealTime HCV assay is intended for use as an aid in the management of HCV-infected patients undergoing antiviral therapy.
Abbott RealTime HCV is engineered to quantify all HCV genotypes (1–6) equally and provide sensitivity, specificity, and dynamic range to meet your laboratory needs.
Accurate quantification is dependent upon a combination of:
- Primer design
- Probe design
- Cycling conditions